Additional Details

  • A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

    Bend Memorial Clinic
    Bend OR. 97701
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA002
    Kansas City KS. 66160
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA026
    St. Petersburg FL. 33707-6129
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA001
    Santa Barbara CA. 93105-4349
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA010
    Los Angeles CA. 900275969
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA013
    Philadelphia PA. 19140
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA006
    Naples FL. 34102-5412
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA003
    Bend OR. 97701
    View Details

  • Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    USA008
    Richmond VA. 23230
    View Details

  • Nucleoside Therapy in Patients With Telomere Biology Disorders

    Boston Childrens Hospital
    Boston MA. 02115
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Community Health Network
    Indianapolis IN. 46237
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Buffalo
    Buffalo NY. 14203
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Hannibal Regional Healthcare System
    Hannibal MO. 63401
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Brigham and Women's Hospital
    Boston MA. 02115
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Baylor College of Medicine
    Houston TX. 77030
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Banner University Medical Center
    Phoenix AZ. 84006
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Oklahoma
    Oklahoma City OK. 73104
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Utah
    Salt Lake City UT. 84103
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    West Virginia University Hospital
    Morgantown WV. 26505
    View Details